U.S. Physical Therapy (NYSE:USPH) Receives Outperform Rating from Barrington Research

U.S. Physical Therapy (NYSE:USPH)‘s stock had its “outperform” rating reaffirmed by Barrington Research in a research note issued to investors on Monday,Benzinga reports. They presently have a $103.00 price target on the stock. Barrington Research’s price target would indicate a potential upside of 25.92% from the company’s previous close.

USPH has been the subject of a number of other research reports. Wall Street Zen lowered U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Sunday, September 21st. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Monday, December 15th. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. dropped their target price on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a report on Monday, November 24th. Four equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $105.33.

U.S. Physical Therapy Price Performance

USPH stock traded up $2.92 on Monday, hitting $81.80. 116,142 shares of the company’s stock traded hands, compared to its average volume of 77,214. U.S. Physical Therapy has a 1-year low of $62.77 and a 1-year high of $93.50. The stock has a fifty day moving average of $77.86 and a 200-day moving average of $80.40. The stock has a market cap of $1.24 billion, a price-to-earnings ratio of 34.28, a P/E/G ratio of 3.25 and a beta of 1.29. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.30.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Tuesday, August 22nd. The company reported $0.90 earnings per share (EPS) for the quarter. The business had revenue of $140.66 million for the quarter. U.S. Physical Therapy had a return on equity of 8.62% and a net margin of 5.71%. On average, analysts forecast that U.S. Physical Therapy will post 2.67 EPS for the current fiscal year.

Hedge Funds Weigh In On U.S. Physical Therapy

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. William Blair Investment Management LLC acquired a new position in U.S. Physical Therapy in the 3rd quarter valued at $29,381,000. American Century Companies Inc. acquired a new stake in shares of U.S. Physical Therapy in the third quarter valued at about $21,940,000. Bahl & Gaynor Inc. increased its stake in shares of U.S. Physical Therapy by 47.6% in the third quarter. Bahl & Gaynor Inc. now owns 474,688 shares of the company’s stock worth $40,325,000 after purchasing an additional 153,054 shares during the period. Bank of America Corp DE lifted its position in shares of U.S. Physical Therapy by 77.2% during the 3rd quarter. Bank of America Corp DE now owns 317,200 shares of the company’s stock worth $26,946,000 after purchasing an additional 138,194 shares during the last quarter. Finally, 4D Advisors LLC bought a new stake in U.S. Physical Therapy during the 3rd quarter valued at approximately $9,344,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.